Media & Resource centre

02 February 2026

News

Smartway Pharmaceuticals welcomed Paul Kohler MP to its headquarters in South Wimbledon in January 2026, where he spent time with senior members of our team discussing how we support access to medicines across the UK and internationally. The visit provided an opportunity to explore how Smartway operates across public and private healthcare systems,...

13 November 2025

News

Medicine shortages are becoming more frequent, impacting patients everywhere. The Royal Pharmaceutical Society (RPS) has stated that “Medicines shortages impair patients’ access to treatment, causing frustration, anxiety and in some cases worsening health”.1 The RPS report also highlighted “There is a growing consensus that the increase in medicines shortages that the...

02 May 2025

News

Supporting Access, Enhancing Safety For over two decades, Smartway has been supporting the NHS, private hospitals, pharmacies and clinics with the reliable supply of unlicensed medicines, particularly during times of medicine shortages and disruptions. Our expertise in sourcing and supplying unlicensed medicines has helped ensure continuity of care for patients when licensed alternatives are unav...

31 October 2024

News

In recent months, patients across the UK who are affected by pancreatic insufficiency, a condition that severely affects digestion and overall health, have faced real personal challenges and distress due to a nationwide shortage of Creon. In response to this crisis, Smartway is sourcing, importing and supplying licensed Canadian Creon, helping to e...

07 March 2024

News

Celebrated on 29 February 2024, the rarest day of the year, Rare Disease Day unites the global rare disease community to address challenges and promote equity in healthcare, diagnosis, and treatment accessibility. It's a day to come together to share knowledge and support, aiming t...

10 November 2023

News

Medicines regulators depend on the reporting of adverse drug reactions (ADRs) to ensure the safety of medicines. Unfortunately, however, all reporting systems suffer from underreporting, which may limit regulators’ ability to comprehensively assess medication safety on an ongoing basis. During Medicines Safety Week, medicine regulators and healthcare authorities from across the globe join ...

26 September 2023

News

Today, we celebrate World Contraception Day (WCD) and recognise the significance of contraceptive medicine, empowering individuals to make informed decisions about their reproductive well-being. This day serves as a reminder of the importance of safe, easily accessible, and effective contraception, contributing to improved health and life satisfaction. The theme this year, 'The Power of...

25 September 2023

News

Today is World Pharmacists Day (WPD) when we celebrate pharmacists' work and positive impact on the health system. Celebrating WPD is important to us as it goes all the way back to our roots – decades ago, as a community pharmacy. It is an event that gives us the opportunity to recogn...

17 September 2023

News

Today is World Patient Safety Day (WPSD). WPSD was established in 2019 by the 72nd World Health Assembly through the adoption of resolution WHA72.6, entitled "Global Action on Patient Safety". WPSD is about raising awareness of the importance of patient engagement. It also aims to educate, increase awareness and ultimately, help reduce pa...

13 September 2023

News

During the summer, Smartway’s EAP team participated in an EMA workshop about the opportunities and challenges of using Real World Data (RWD) and Real World Evidence (RWE) in regulatory processes. The workshop, conducted by the European Medicines Agency (EMA), a body dedicated to driving excellence in evaluating and supervising medicines for public health in the European Union (EU), was ...

10 August 2023

News

Marius Pharmaceuticals (Marius) and Smartway Pharmaceuticals (Smartway) are pleased to announce their strategic partnership, aimed at addressing the pressing global issue of hypogonadism through the launch of a comprehensive Early Access Program for KYZATREX™ (testosterone undecanoate). Hypogonadism, a prevalent medical condition affecting millions of men worldwide, is characterized by low testosterone levels, which can lead to a range o...

03 May 2023

News

Ambrose Healthcare and Smartway Pharmaceuticals have signed an agreement for the provision of international Early Access Programs for Ambrose products. About Ambrose Healthcare  Ambrose Healthcare is a specialist pharmaceutical company with ambitious plans to address unmet medical needs in rare disease. The company will provide treatments for use in hospitals or specialist care environments. The US National Institutes of Heal...